Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection
about
Chikungunya Virus: In Vitro Response to Combination Therapy with Ribavirin and Interferon-α2aSerum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin.Influence of Ribavirin Serum Levels on Outcome of Antiviral Treatment and Anemia in Hepatitis C Virus Infection.Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C VirusPlasma and intracellular ribavirin concentrations are not significantly altered by abacavir in hepatitis C virus-infected patients.Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials.Liquid chromatography-mass spectrometry methods for the intracellular determination of drugs and their metabolites: a focus on antiviral drugs.Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.Variant Inosine Triphosphatase Phenotypes Are Associated With Increased Ribavirin Triphosphate Levels.A LC-MS/MS Method for Quantifying Adenosine, Guanosine and Inosine Nucleotides in Human Cells.Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus.
P2860
Q26247966-4ED443DA-84E5-4FED-8B73-8B303F3B62A6Q35975174-B10C6198-EE2C-4C46-9FB5-4B4C74925152Q36070215-0AF5A5BF-CE05-422D-8243-B68598758E43Q36600070-129F6D38-C6BF-470A-B1DB-C2D8F5ED2796Q36901498-9FC942C4-CD61-4E02-A64A-C481A2D49A73Q39357557-13E7579A-9CE1-4D67-971C-B826E934D122Q39434360-BA3259B3-DBFD-469D-A983-F298D67A2745Q40280603-D67CA511-F7A1-4697-AD90-1F63DB3F6C64Q40385212-8463D247-808A-443C-8E77-F4671D185E72Q49810962-C5990FF6-2ADE-4939-942E-2586A9996690Q50028149-5F158B97-3FC0-4452-B87B-67EE65C77BD9
P2860
Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Population pharmacokinetic mod ...... ic hepatitis C virus infection
@ast
Population pharmacokinetic mod ...... ic hepatitis C virus infection
@en
type
label
Population pharmacokinetic mod ...... ic hepatitis C virus infection
@ast
Population pharmacokinetic mod ...... ic hepatitis C virus infection
@en
prefLabel
Population pharmacokinetic mod ...... ic hepatitis C virus infection
@ast
Population pharmacokinetic mod ...... ic hepatitis C virus infection
@en
P2093
P2860
P356
P1476
Population pharmacokinetic mod ...... ic hepatitis C virus infection
@en
P2093
David Z D'Argenio
Fafa Baouchi-Mokrane
Gregory T Everson
James R Burton
Jennifer J Kiser
Joseph E Rower
Kyle P Hammond
Liviawati S Wu
Peter L Anderson
Thomas J Urban
P2860
P304
P356
10.1128/AAC.04618-14
P407
P577
2015-02-02T00:00:00Z